Goldman Sachs Removes Baxter International (BAX) from Conviction Buy List
Tweet
Share
E-mailGet Alerts BAX Hot Sheet
Price: $26.73 -1.18%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs removed Baxter International (NYSE: BAX) from the Conviction Buy List but is keeping its Buy rating. The price target moves from $60 to $59.
The firm said their original thesis largely has played out, and now see better opportunities across healthcare. Over the long-term, Goldman continues to see see Baxter as one of the best positioned companies in the sector.
For an analyst ratings summary and ratings history on Baxter International click here. For more ratings news on Baxter International click here.
Shares of Baxter International closed at $48.41 yesterday.
The firm said their original thesis largely has played out, and now see better opportunities across healthcare. Over the long-term, Goldman continues to see see Baxter as one of the best positioned companies in the sector.
For an analyst ratings summary and ratings history on Baxter International click here. For more ratings news on Baxter International click here.
Shares of Baxter International closed at $48.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- RBC Capital Downgrades CareTrust REIT (CTRE) to Sector Perform
- Northcoast Downgrades Brinker Int'l (EAT) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
